The Influence of Placental Drainage of Management of the Third Stage of Labor:a Randomized Controlled Study
1 other identifier
interventional
485
1 country
1
Brief Summary
To determine whether early placental drainage plus cord traction reduces the incidences of manual removal and blood loss, and to determine the risk factors associated with blood loss after delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2013
CompletedFirst Posted
Study publicly available on registry
August 29, 2013
CompletedStudy Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedMarch 10, 2014
November 1, 2013
3 months
August 26, 2013
March 7, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
postpartum blood loss
24 hours
Study Arms (2)
Drainage Group
PLACEBO COMPARATORearly placental drainage plus cord traction
Controlled Group
NO INTERVENTIONspontaneous removal placenta
Interventions
Eligibility Criteria
You may qualify if:
- greater than 37 gestational weeks
- single pregnancy
- vaginal delivery
- estimated fetal weight 2500-4500 gr.
You may not qualify if:
- PPROM
- or lower gestational week
- multiple pregnancy
- grand multiparıty (greater than 5)
- coagulation defects (HELLP, ablation placenta, previa, pre-eclampsia)
- a history of any bleeding during pregnancy
- caesarean delivery or any uterine scar
- a history of postpartum haemorrhage
- hydramnios
- known uterine anomalies
- suspected abnormal placentation (accreta, increta, or percreta)
- prepartum hemoglobin concentration less than 8 g/dL
- history of anticoagulant drugs and prolongation of the first stage of labor longer than 15 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Osman Aşıcıoğlu
Istanbul, ŞiŞLİ, 32744, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Osman Aşıcıoğlu, M.D.
T.C.S.B. Şişli Etfal Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D. Obstetric and Gynecology
Study Record Dates
First Submitted
August 26, 2013
First Posted
August 29, 2013
Study Start
November 1, 2013
Primary Completion
February 1, 2014
Study Completion
March 1, 2014
Last Updated
March 10, 2014
Record last verified: 2013-11